Elvina Almuradova: ctDNA/MRD testing shows promise in guiding colon cancer treatment
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post on X about a recent paper by Bennett Caughey and Aparna Parikh published in JNCCN:
“ctDNA/MRD testing shows promise in guiding colon cancer treatment, but more research is needed before it becomes standard. Early trials suggest it can help personalize chemo decisions. Stay tuned for updates!”
“ctDNA/MRD Testing for Colon Cancer: A Work in Progress or Ready for Prime-Time Standard of Care?”
Authors: Bennett Caughey and Aparna Parikh.
More posts featuring Elvina Almuradova.
Dr. Elvina Almuradova is an Associate Professor of Oncology at the European Institute of Oncology (IEO) and an Ambassador for the European School of Oncology. Her expertise encompasses basic oncology, chemotherapy, cancer biomarkers, diagnostics, and cancer cell biology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023